Relationships between structure and high-throughput screening permeability of peptide derivatives and related compounds with artificial membranes: application to prediction of Caco-2 cell permeability.
暂无分享,去创建一个
Ryuichi Matsuno | Miki Akamatsu | Tamio Ueno | M. Akamatsu | R. Matsuno | Rieko Ano | Yukitaka Kimura | Motohiro Shima | Rieko Ano | Y. Kimura | M. Shima | T. Ueno
[1] Yi Han,et al. Predicting Caco-2 Cell Permeation Coefficients of Organic Molecules Using Membrane-Interaction QSAR Analysis , 2002, J. Chem. Inf. Comput. Sci..
[2] K. Luthman,et al. Correlation of drug absorption with molecular surface properties. , 1996, Journal of pharmaceutical sciences.
[3] I Moriguchi,et al. Non-congeneric structure-pharmacokinetic property correlation studies using fuzzy adaptive least-squares: oral bioavailability. , 1994, Biological & pharmaceutical bulletin.
[4] K Gubernator,et al. Physicochemical high throughput screening: parallel artificial membrane permeation assay in the description of passive absorption processes. , 1998, Journal of medicinal chemistry.
[5] J. Riordan,et al. The mdr1 gene, responsible for multidrug-resistance, codes for P-glycoprotein. , 1986, Biochemical and biophysical research communications.
[6] B. Faller,et al. High-throughput permeability pH profile and high-throughput alkane/water log P with artificial membranes. , 2001, Journal of medicinal chemistry.
[7] C. Pidgeon,et al. IAM chromatography: an in vitro screen for predicting drug membrane permeability. , 1995, Journal of medicinal chemistry.
[8] P. Carrupt,et al. Molecular fields in quantitative structure–permeation relationships: the VolSurf approach , 2000 .
[9] D. B. Boyd. Quantum Chemistry Program Exchange. , 1999, Journal of molecular graphics & modelling.
[10] M. Machida,et al. High Throughput Prediction of Oral Absorption: Improvement of the Composition of the Lipid Solution Used in Parallel Artificial Membrane Permeation Assay , 2001, Journal of biomolecular screening.
[11] Kin-Kai Hwang,et al. A comparative study of artificial membrane permeability assay for high throughput profiling of drug absorption potential. , 2002, European journal of medicinal chemistry.
[12] M Pastor,et al. VolSurf: a new tool for the pharmacokinetic optimization of lead compounds. , 2000, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.
[13] Peter C. Jurs,et al. Prediction of Human Intestinal Absorption of Drug Compounds from Molecular Structure , 1998, J. Chem. Inf. Comput. Sci..
[15] P. Augustijns,et al. Use of Caco-2 cells and LC/MS/MS to screen a peptide combinatorial library for permeable structures. , 1999, International journal of pharmaceutics.
[16] S. Wold,et al. The Collinearity Problem in Linear Regression. The Partial Least Squares (PLS) Approach to Generalized Inverses , 1984 .
[17] H. Terada,et al. Partition and Ion-pair Partition of 2, 4-Dinitrophenol, an Uncoupler of Oxidative Phosphorylation , 1981 .
[18] P. Goodford. A computational procedure for determining energetically favorable binding sites on biologically important macromolecules. , 1985, Journal of medicinal chemistry.
[19] Y. Kanai,et al. Cloning and Characterization of a Novel Multispecific Organic Anion Transporter * , 1997 .
[20] T. Vidmar,et al. Strategies toward predicting peptide cellular permeability from computed molecular descriptors. , 1999, The journal of peptide research : official journal of the American Peptide Society.
[21] Sean Ekins,et al. Three-Dimensional Quantitative Structure-Permeability Relationship Analysis for a Series of Inhibitors of Rhinovirus Replication , 2001, J. Chem. Inf. Comput. Sci..
[22] Han van de Waterbeemd,et al. Estimation of Caco‐2 Cell Permeability using Calculated Molecular Descriptors , 1996 .
[23] John G. Topliss,et al. QSAR Model for Drug Human Oral Bioavailability1 , 2000 .
[24] T. Fujita,et al. Hydrophobicity of Di‐ and Tripeptides Having Unionizable Side Chains and Correlation with Substituent and Structural Parameters , 1989 .
[25] T. Fujita,et al. Hydrogen-bonding parameter and its significance in quantitative structure--activity studies. , 1977, Journal of medicinal chemistry.
[26] M. Yazdanian,et al. Correlating Partitioning and Caco-2 Cell Permeability of Structurally Diverse Small Molecular Weight Compounds , 1998, Pharmaceutical Research.
[27] A. Berglund,et al. Structure-property model for membrane partitioning of oligopeptides. , 2000, Journal of medicinal chemistry.
[28] U Norinder,et al. Experimental and computational screening models for the prediction of intestinal drug absorption. , 2001, Journal of medicinal chemistry.
[29] K. Iseki,et al. Development of a new system for prediction of drug absorption that takes into account drug dissolution and pH change in the gastro-intestinal tract. , 2001, International journal of pharmaceutics.
[30] M. Hashida,et al. Prediction of Caco-2 cell permeability using a combination of MO-calculation and neural network. , 2002, International journal of pharmaceutics.
[31] J. Stewart. Optimization of parameters for semiempirical methods II. Applications , 1989 .
[32] Kiyohiko Sugano,et al. Prediction of passive intestinal absorption using bio-mimetic artificial membrane permeation assay and the paracellular pathway model. , 2002, International journal of pharmaceutics.
[33] P. Artursson,et al. Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. , 1991, Biochemical and biophysical research communications.